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Chylous ascites caused by acute pancreatitis with portal 
vein thrombosis
Dong Eun Park, Kwon Mook Chae
Department of Surgery, Wonkwang University Hospital, Wonkang University College of Medicine, Iksan, Korea
Chylous ascites is defined as the accumulation of chyle in the peritoneum due to obstruction or rupture of the peritoneal or 
retroperitoneal lymphatic glands. Chylous ascites that arises from acute pancreatitis with portal vein thrombosis is very rare. 
We report here on a case of chylous ascite that was caused by acute pancreatitis with portal vein thrombosis, in which the pa-
tient showed an impressive response to conservative therapy with total parenteral nutrition and octerotide. We also review 
the relevant literature about chylous ascites with particular reference to the management of this rare disease.
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INTRODUCTION
Since Morton’s dramatic and detailed account in 1694 of 
a 2-year-old boy who died with chylous ascites (caused by 
tuberculosis), the accumulation of chylous fluid in the per-
itoneal cavity is known to be a rare condition [1]. The ma-
jority of cases in adults are attributed to malignancies, 
while congenital lymphatic abnormalities are involved in 
the pediatric population. Most of the patients with chylous 
ascites are known to have a poor outcome because of the 
high proportion of malignancy being the cause of chylo-
peritoneum. We concluded that acute pancreatitis with 
portal vein thrombosis was the cause of chylous ascites in 
this currently reported case. In this case, an inflammatory 
process of the pancreatitis could have initiated structural 
and functional damage to the main lymphatic tissue; and 
the portal hypertension due to portal vein thrombosis 
served as an aggregating factor to increase the chylous 
ascites. We report here on an uncommon case of chylous 
ascites following acute pancreatitis with portal vein 
thrombosis in which the patient responded to only paren-
teral nutrition and octreotide.
CASE REPORT
A 63-year-old man visited our hospital for his increasing 
abdominal distension during the previous 2 months. For 
his medical history, he received operative management for 
meningioma of the brain. He was diagnosed as having 
portal vein thrombosis due to acute pancreatitis in April 
2009 (Fig. 1), and since then had taken medication (warfar-Chylous ascites related acute pancreatitis
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Fig. 1. Computed tomography scan showing portal vein throm-
bosis with cavernous change of portal vein before chylous ascites 
occurred. 
Fig. 2. Computed tomography scan showing large amount of ascites with portal vein thrombosis and head of pancreas showed edematous 
enlargement with mild pancreatic duct dilatation.
in) for 1-year. He had no risk factors for chronic liver 
disease. After the brain operation, he has been bed ridden 
for over half a day, daily, due to motor weakness after the 
surgical management of meningioma. He experienced 
weight loss of 4 kg during the next 6 months and experi-
enced persistent anorexia. On physical examination, we 
did not detected any specific findings except for shifting 
dullness within a distended abdomen.
For the laboratory studies, the hemoglobin level, white 
blood cell and platelet count was 11.6 g/uL (normal range, 
13 to 18), 4.66 × 10
3/uL (normal range, 4 to 10), and 137 × 
10
3/uL (normal range, 150 to 450), respectively. The liver 
function tests disclosed an aspartate aminotransferase lev-
el of 30 IU/L (normal range, 5 to 35), an alanine amino-
transferase level of 20 IU/L (normal range, 5 to 40), an alka-
line phosphatase level of 344 IU/L (normal range, 104 to 
338), a total bilirubin level and direct bilirubin level of 0.67 
mg/dL (normal range, 0.2 to 1.4) and 0.25 mg/dL (normal 
range, 0 to 0.7), respectively; an albumin level of 3.8 g/dL 
(normal range, 3.8 to 5.1), an amylase level of 155 IU/L 
(normal range, 28 to 100) and a lipase level of 47 IU/L 
(normal range, 13 to 60). We did not find any factors that 
could give rise to portal vein thrombosis. 
Abdominal computed tomography (CT) revealed the 
portal vein thrombosis from the intrahepatic portal vein to 
the proximal part of the superior mesenteric vein and 
there was a cavernous transformation of the portal vein 
with a patent hepatic vein and splenic vein. A large 
amount of ascites in the perihepatic, subphrenic, paracolic 
and pelvic spaces were present. There was also edematous 
change of the pancreas head and body without lympha-
denopathy or a fluid collection (Fig. 2). Paracentesis 
drained some of the milky whitish color fluid with a high 
triglyceride level of 57 mg/L and an albumin level of 1.3 
g/L, which is consistent with chylous ascites (Fig. 3). On 
the cell count analysis of the ascitic fluid, the red blood 
cells were 920/μL and the white blood cells were 150μL 
(polymorphous nuclear cells, 10% and mononuclear cells, 
90%). The chylous ascites caused by infection could be ex-
cluded because acid fast bacilli stain and culture, gram 
stain and culture, fungal culture and polymerase chain re-Dong Eun Park and Kwon Mook Chae
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Fig. 3. Paracentesis drained some of milky whitish color fluid with 
high triglyceride level of 577 mg/L and albumin level of 1.3 g/L, 
which is consistent with chylous ascites.
Fig. 4. Positron emission tomography-computed tomography 
showed hot uptake of radioactive agent in only entire pancreas 
without abnormal uptake of peritoneal organs and lymph nodes.
action for tuberculosis were all negative. The serum α-fe-
toprotein and carcinoembryonic antigen were within the 
normal ranges. The serum CA19-9 levels were raised to 
279 IU/mL (0 to 33). We performed flourodeoxyglu-
cose-positron emission tomography-CT (FDG-PET-CT) to 
exclude internal malignancy. PET-CT showed the hot up-
take of radioactive agent in only the entire pancreas with-
out abnormal uptake of the peritoneal organs and lymph 
nodes (Fig. 4). The 5-hydroxyindolacetic acid titer was also 
unremarkable. The histologic examination of the chylous 
ascites also showed reactive change without malignant 
cells or dysplastic cells. Immunohistologic testing of the 
patient’s serum was performed to exclude autoimmune 
pancreatitis. Serum immunoglobulin (Ig) G and IgG sub-
class 4 was 1,697 mg/dL (range, 700 to 1,600) and 527.0 
mg/dL, respectively. Anti-nuclear antibody and anti-mi-
tochondrial antibody were negative. Esophagogastroduo-
denoscopy showed esophageal varix of grade I to II. 
Lymphoscintigraphy was not performed. We concluded 
that the chylous ascites was caused by portal vein throm-
bosis with acute pancreatitis. He was treated with diu-
retics, total parenteral nutrition and octreotide. After 1 
week, he showed improvement of distended abdomen 
and this management option was maintained for three 
weeks with a lower fatty diet with median chain trigly-
cerides (MCT) supplementation. Since then, he was con-
tinuously treated with a lower fatty diet with MCT and 
diuretics. The decrease in the chylous ascites was con-
firmed by follow-up CT scan. During follow-up every 3 
months, the CA19-9 level of the serum was increased to 
more than 1,000 IU/mL without an increase of the chylous 
ascites. We re-evaluated the patient to find evidence of in-
ternal malignancy; except for a high CA19-9 level, we 
could not find evidence of malignancy. 
DISCUSSION
Chylous ascites is a rare form of ascites and this is char-
acterized by a milky fluid that contains a high level of 
triglycerides. The diagnosis of chylous ascites requires 
peritoneal fluid with at least one of the following criteria 
[2]: peritoneal lipid content greater than that of plasma, a 
peritoneal to plasma protein concentration ratio of ＞0.5, a 
triglyceride concentration ＞110 mg/dL, and microscopic 
fat. The incidence of chylous ascites is from 1 in 20,000 to 1 
in 187,000 admissions at large tertiary referral hospitals 
[3].
The mechanisms for the formation of chylous ascites are 
related to the following: 1) primary lymph node invasion 
by malignancy obstructing lymph flow, resulting in leak-
age of lymph from the subserosal lymphatics into the peri-
toneal cavity, 2) exudation of lymph through congenital 
retroperitoneal megalymphatics, 3) obstruction of the 
thoracic duct by trauma resulting in leakage of chyle, and Chylous ascites related acute pancreatitis
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4) increasing caval or hepatic pressure from congestive 
conditions such as right side heart failure and liver cir-
rhosis [4].
The causes of chylous ascites can roughly be divided in-
to traumatic and atraumatic. For traumatic causes, surgi-
cal procedure and therapeutic intervention are well 
known causes of chylous ascites. Especially, surgeries that 
require dissecting lymphatic tissues such as oncological 
surgeries are known to frequently cause chylous ascites. 
For patients undergoing abdominal or retroperitoneal 
surgery, the incidence of postoperative chylous ascites 
was reported to be from 1.1 to 7.4% [5]. An additional 
cause of indirect injury leading to the development of chy-
lous ascites is radiation. The abdominal radiation that 
causes chylous ascites is thought to induce fibrosis of the 
lymphatic vessels within the small bowel and the mesen-
tery; this causes obstruction and subsequent extravasation 
of chylous [6]. The finding of atraumatic chylous ascites 
should always prompt the surgeon to rule out these seri-
ous underlying causes. In the pediatric population, the 
predominant cause of chylous ascites is known to be lym-
phatic anomalies in up to 84% of the cases [7]. In contrast, 
malignancies, liver cirrhosis, and mycobacterium in-
fections are known as the major causes in the adult 
population. Lymphatic anomalies account for only for 9% 
of the cases of atraumatic chylous ascites in adults [8]. 
According to a review of the literature, 13 cases have 
been reported during the last several decades: there were 
seven cases of chylous ascites associated with chronic pan-
creatitis, one case associated with chronic relapsing pan-
creatitis and only five cases associated with acute pan-
creatitis [8]. Our case showed different clinical findings 
when compared with those of the previously reported 
cases. First, our case had portal vein thrombosis with cav-
ernous change of the portal vein before the formation of 
chylous ascites. This finding and the acute pancreatitis 
finding that was shown in 18 FDG-PET-CT had an influ-
ence on the development of the chylous ascites, although 
this case did not show the typical clinical findings and lab-
oratory findings of acute pancreatitis. Second, we cannot 
exclude pancreatic cancer or internal malignancy because 
of the continuously high CA19-9 level of the serum. At this 
point it is difficult to say for sure what caused the chylous 
ascites in this patient.
Different therapeutic options have been described for 
the management of chylous ascites, including surgery, oc-
treotide and a low fat diet with medium chain triglyceride 
supplementation with parenteral nutrition [6,9]. Aalami et 
al. [6] were retrospectively reviewed in case reports ac-
cording to therapeutic option. The patients who were in-
cluded had chylous ascites from multiple causes that re-
solved after either medical or surgical intervention. One 
fifth of the total 156 patients was treated surgically; 105 pa-
tients were treated conservatively. The patients were first 
treated with conservatively, followed-up with total paren-
teral nutrition, high protein with low fat diet, and 
paracentesis. Octreotide also is available for control of 
chylous ascites. Octreotide decreases splanchnic and por-
tal blood flow, portal pressure and postprandial hyper-
emia response in portal hypertensive patients without 
having significant effects upon the systemic circulation 
[10]. Surgical exploration is recommended for chylous as-
cites with a benign histological cause that has been re-
fractory to an appropriative trial of vigorous nonoperative 
treatment. Leong et al. [10] first reported the use of octreo-
tide in chylous ascites caused by portal hypertension in 
portal vein thrombosis. Of all the patients, 67% were suc-
cessfully treated conservatively, and 33% were success-
fully treated surgically [6]. Our patient showed a good re-
sponse with a decreasing amount of chylous ascites within 
a few weeks after being treated with parenteral nutrition, 
octreotide injection and administering diuretics.
In spite of the high serum CA19-9 levels, our patient is 
alive without having developed chylous ascites or internal 
malignancy during 2 years of follow-up.
We have reported here on an unusual case of chylous as-
cites that was caused by acute pancreatitis with portal hy-
pertension that improved by administering total paren-
teral nutrition with the patient in a fasting state, octreotide 
injection and diuretics. 
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